Skip to main content

Shania Twain on her ‘very long road’ to getting it right

▶ Watch Video: Shania Twain on “Little Miss Twain”

She can command a stadium crowd, but spend some time with Shania Twain and you’ll see she may be most herself with the horses. “I just love being with them,” she said. “I ride in my pajamas in the mornings! … It’s just a great escape.”  

shania-twain-and-seth-doane-riding-in-hyde-park-london.jpg
Shania Twain and Seth Doane riding in Hyde Park, London.

CBS News

It sounds a little like how she sees music, that other passion, which made her the top-selling female country artist of all time. Sometimes she’ll blend the two, taking her horses on tour, which she admits takes some planning.  

We joined her for a ride in Hyde Park on a down day between performances at London’s Wembley Stadium, where we’d just seen her electrify the audience. She’d gotten an invite from Harry Styles to join him as his special guest for 12 nights at Wembley in June.

shania-twain-wembley-1280.jpg
Shania Twain performs at Wembley Stadium in London.

CBS News

Watching her perform, it’s hard to imagine that Twain has suffered from stage fright. “The amount of people is not necessarily what affected me over the years with stage fright,” she said. “It was starting so young in bars that were, you know, I was eight years old, and the bars were smoky, and everyone was intoxicated. I don’t know what I’m actually singing about, because I’m singing about divorce, and I’m eight.”

Twain grew up poor in rural Ontario, Canada, but her mom recognized riches and potential in her voice, and would ferry her to bars to sing. As a minor, Twain was only allowed on stage after last call. “This was just an uncomfortable place to be as a child, and I carried that with me,” she said. “And only in my 50s, I finally just said, Whoa. I’ve got my voice. I have an audience. I have everything to just celebrate. And the fear just dropped away.”

She reminisces about all of this in her new album, “Little Miss Twain,” out later this month.

little-miss-twain-cover-republic-records-umg-900.jpg

Republic Records/UMG

“‘Little Miss Twain’ is me, now, looking back at my child’s self and the journey that child went through, from starting out in those bars at eight years old, right up to when I got my recording contract in Nashville,” she said. “I didn’t get a contract until I was in my late 20s. My first Top 10 record, I was 30 already. So, there’s all of these years that were me making a living with singing in bars as a cover singer, collecting all of the songwriting that would end up becoming the Shania Twain records.”

She was “Eileen Twain,” until someone at her record label suggested she change her name. This new album reflects the process of going from being Eileen to being Shania. “It’s the bridge,” she said.

As Shania, she’d become the star her mother dreamed of.

To hear Shania Twain perform “Little Miss Twain,” click on the video player below:

According to my mother, I’m the next Tanya Tucker
She drives me to sing in the bar
Push start the Chevy, it’s old and it’s heavy
And I’m still smaller than my guitar
Smoking like a chimney, coachin’ it in me
“Honey, you’re gonna go far”
According to my mother, I’m the next Tanya Tucker
I’m gonna be a star
Yeah, I’m gonna be a star
 

“When I was younger, I was so over-responsible for the household,” said Twain. “My mother was depressed a lot of the time. She spent a lot of her days in bed. She lived off coffee and cigarettes that I would bring her in bed just to see if she was still alive. There was a lot of violence in the house. And we didn’t eat well a lot of the times. We weren’t clothed properly a lot of the time. …

“When I reflect back on those times, I’m reflecting on them from where I am now, which is a very good place. Like, I made it out of there. It’s like, Whoa, I’m just celebrating all of that. And what makes me feel so accomplished, is staying connected to where I came from. It’s the contrast that makes it feel so good.”

Her parents would never see her success; they died in a car crash when she was 22, and Twain became guardian of her younger siblings. Challenges came later as well: divorce from her record producer-husband, Mutt Lange, who collaborated on many of her hits. Then, the loss of her voice due to Lyme disease. She did not release any music for 15 years.

She had experimental open throat surgery to bring her voice back. “Once I made a sound, it was just there,” she said. “I feel lucky. I don’t want to make it sound easy! It wasn’t easy, it was a very long road, but I just feel very grateful and very lucky that I have it back.”

Her voice is different: “I have more, like, of a fry to my voice, you know, a little gravel. I don’t mind that. I’ve embraced it. It’s now part of my sound.”

Asked how she changes her sound mid-career, she laughed: “I know, tell me about it! How does one do that? You just adapt. I’ve taken a different approach to singing my older songs. In fact, I’ve found new placements in my voice that I enjoy, you know, that I didn’t have before.

“I love to experiment. I think it’s the same with any art form. You have to experiment a little bit to get just the right – whatever’s satisfying you the most at that time, you know?” she said.

Asked what the itch was that she scratched with her latest album, she replied, “This album was indulging in reflection of my life with a smile.”

shania-twain-int-a-1280.jpg
Shania Twain.

CBS News

Twain remarried, to Frédéric Thiébaud, and lives in Switzerland. Looking back, she is remarkably forgiving of her parents. It’s all part of what’s allowing her to celebrate her past. 

“I started life out a little bit on the tough side,” she said. “In my 60s now, I feel like I’ve really gotten it, or I’m just now getting all of that right.”

Asked what it is about her 60s that enabled her to “get” it right, Twain replied, “You know what it is? It’s called time. I’d love to have been able to get it right in my 50s, but I just – that wasn’t enough time. I needed to be in my 60s to start getting it right, you know? And that’s fine. I plan to live to be 200 anyway!”

Sounds like a good song! “That does, doesn’t it?” she laughed. “I better live to be 200, to get everything in that I want to get in.”

WEB EXCLUSIVE: Watch an extended interview with Shania Twain (Video)

Extended interview: Shania Twain

26:24

     
For more info:

    
Story produced by Mikaela Bufano. Editor: Steven Tyler. 


See also: 

La prueba de sangre para el alzhéimer de Roche y Eli Lilly recibe autorización de la FDA

La Administración de Alimentos y Medicamentos de EE.UU. autorizó la prueba de sangre de Roche y su socio Eli Lilly para ayudar a identificar indicios de la enfermedad de Alzheimer en personas de 55 años o más con deterioro cognitivo.La prueba, Elecsys pTau217, es un análisis de sangre de biomarcadores que puede ayudar a los médicos a identificar a los pacientes que probablemente presentan o no cambios cerebrales relacionados con el alzhéimer, informó Roche el lunes.La autorización de la FDA se produce después de que la prueba fuera aprobada en Europa en mayo.La prueba puede realizarse en más de 4.500 analizadores de laboratorio de Roche ya instalados en Estados Unidos, lo que, según la empresa, podría ayudar a ampliar el acceso. Labcorp y Quest Diagnostics dijeron que planean ofrecer la prueba a través de sus redes de laboratorios, lo que podría aumentar su disponibilidad.Roche no reveló el precio de la prueba.La autorización de la FDA se produce mientras los fabricantes de medicamentos y las empresas de diagnóstico compiten por desarrollar pruebas más sencillas para detectar la enfermedad de Alzheimer y satisfacer la creciente demanda de diagnóstico y tratamiento tempranos.Lumipulse, de Fujirebio, se convirtió en 2025 en la primera prueba de sangre autorizada por la FDA para ayudar a evaluar la enfermedad de Alzheimer. La prueba Elecsys pTau181 de Roche y Lilly, que mide una proteína diferente a la de la prueba recién autorizada, también recibió el visto bueno de la FDA el año pasado. La semana pasada, la agencia autorizó la prueba Precivity AD2 de C2N Diagnostics.Tradicionalmente, el diagnóstico del alzhéimer requería procedimientos costosos e invasivos, como tomografías por emisión de positrones o punciones lumbares. Sin embargo, las pruebas de sangre que miden los niveles del biomarcador tau fosforilada 217, o p-tau217, “predicen con gran precisión” la acumulación de placas pegajosas de beta-amiloide en el cerebro, dijo a CNN a principios de este año Rachel Buckley, profesora asociada de neurología de la Facultad de Medicina de Harvard.Las placas amiloides, que causan inflamación y perjudican la comunicación entre las neuronas, pueden acumularse en el cerebro décadas antes de la pérdida de memoria o el deterioro cognitivo, incluso cuando las personas tienen entre 30 y 49 años.A medida que aumentan los niveles de beta-amiloide en el cerebro, ovillos de proteínas llamadas tau comienzan a acumularse dentro de las células cerebrales, lo que hace que las neuronas colapsen y mueran. En algunas enfermedades, como la demencia del lóbulo frontal, que afecta la función ejecutiva en lugar de la memoria, los ovillos pueden acumularse sin la presencia de amiloide.No todas las personas con niveles elevados de amiloide desarrollarán demencia, del mismo modo que tener tau en el cerebro no determina que habrá deterioro cognitivo más adelante en la vida, indicó Buckley.Elecsys pTau217 no está diseñada para utilizarse como una prueba diagnóstica independiente y sus resultados deben interpretarse junto con otra información clínica, indicó Roche.“Las ‘pruebas de sangre para el alzhéimer’ individuales pueden plantear numerosos desafíos, y esta nueva prueba no es diferente”, dijo el lunes a CNN por correo electrónico el doctor Richard Isaacson, investigador en prevención del alzhéimer y director de investigación del Instituto de Enfermedades Neurodegenerativas de Florida.“Al igual que cuando un médico solicita una prueba de colesterol, ¿alguna vez pide una sola prueba? No: solicita un panel de pruebas, y esa es la estrategia que recomiendo para reducir al mínimo la confusión y mejorar la precisión del diagnóstico clínico y de la predicción del riesgo”.Isaacson señaló que la nueva prueba “tiene un valor predictivo negativo suficiente (la probabilidad de que descarte correctamente un diagnóstico de la enfermedad de Alzheimer)”, pero afirmó que “el valor predictivo positivo no es muy bueno”.“Los resultados falsos positivos son un problema en la práctica clínica, por lo que debemos tener cuidado (especialmente con una prueba nueva como esta, que tiene clasificaciones positivas, negativas E indeterminadas)”, escribió. Los problemas con la forma en que se manipulan las muestras o la presencia de otras afecciones médicas, como problemas renales o enfermedades virales, también pueden generar confusión al interpretar los resultados.En lugar de utilizar las pruebas de sangre de p-tau217 y amiloide para el diagnóstico, Isaacson las realiza para buscar indicios de cómo responden las personas al tratamiento y a los cambios en el estilo de vida.Las intervenciones personalizadas en el estilo de vida, como una mejor alimentación, ejercicio, sueño y socialización —combinadas con el control de la insulina, el colesterol y otros factores de riesgo según sea necesario— han reducido los niveles de amiloide y tau en pacientes comprometidos con mejorar su salud.“Las investigaciones ahora muestran que hasta el 45 % de los casos de demencia pueden prevenirse con intervenciones en el estilo de vida, como ejercicio, alimentación, interacción social, entrenamiento cognitivo y control de los factores de riesgo vasculares y metabólicos”, dijo a CNN a principios de este año Laura Nisenbaum, directora científica interina de la Fundación para el Descubrimiento de Fármacos contra el Alzhéimer, que financia investigaciones sobre esa enfermedad.The-CNN-Wire™ & © 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.
Read Next Story